Drifa Belhadi

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

Clairelyne Dupin, Drifa Belhadi, Laurent Guilleminault et al. · Clinical & Experimental Allergy · 2020 · 136 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · Clinical Microbiology and Infection · 2021 · 107 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +14

Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort

Gaëlle Dauriat, Martine Reynaud‐Gaubert, Vincent Cottin et al. · The Journal of Heart and Lung Transplantation · 2021 · 49 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial

Guillaume Lingas, Nadège Néant, Alexandre Gaymard et al. · Journal of Antimicrobial Chemotherapy · 2022 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10